Ingrid Kane
Hoofd Techniek/Wetenschap/O&O bij SIGHT SCIENCES, INC.
Profiel
Ingrid Kane is currently the Vice President-Global Medical Affairs at Sight Sciences, Inc. Previously, she worked as the Vice President-Medical Affairs at iScience Interventional Corp.
She holds a doctorate degree from the University of Charles.
Actieve functies van Ingrid Kane
Bedrijven | Functie | Begin |
---|---|---|
SIGHT SCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Ingrid Kane
Bedrijven | Functie | Einde |
---|---|---|
iScience Interventional Corp.
iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Ingrid Kane
University of Charles | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SIGHT SCIENCES, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
iScience Interventional Corp.
iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA. | Health Services |